Astellas Pharma Inc
OTC:ALPMY
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.88
14.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
ALPMY
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 14.1 USD,
Astellas Pharma Inc
is
hidden
.
Valuation History
Astellas Pharma Inc
ALPMY looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ALPMY usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Astellas Pharma Inc.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Astellas Pharma Inc
Balance Sheet Decomposition
Astellas Pharma Inc
Astellas Pharma Inc
Free Cash Flow Analysis
Astellas Pharma Inc
| JPY | |
| Free Cash Flow | JPY |
Earnings Waterfall
Astellas Pharma Inc
ALPMY Profitability Score
Profitability Due Diligence
Score
ALPMY Solvency Score
Solvency Due Diligence
Score
Wall St
Price Targets
ALPMY Price Targets Summary
Astellas Pharma Inc
According to Wall Street analysts, the average 1-year price target for
ALPMY
is 12.27 USD
with a low forecast of 8.39 USD and a high forecast of 16.09 USD.
Dividends
Current shareholder yield for
Astellas Pharma Inc is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ALPMY
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 14.1 USD,
Astellas Pharma Inc
is
hidden
.